全文获取类型
收费全文 | 14318篇 |
免费 | 1199篇 |
国内免费 | 260篇 |
专业分类
耳鼻咽喉 | 59篇 |
儿科学 | 232篇 |
妇产科学 | 59篇 |
基础医学 | 1040篇 |
口腔科学 | 95篇 |
临床医学 | 1227篇 |
内科学 | 1059篇 |
皮肤病学 | 158篇 |
神经病学 | 61篇 |
特种医学 | 1101篇 |
外国民族医学 | 1篇 |
外科学 | 2983篇 |
综合类 | 1479篇 |
预防医学 | 583篇 |
眼科学 | 33篇 |
药学 | 1940篇 |
8篇 | |
中国医学 | 517篇 |
肿瘤学 | 3142篇 |
出版年
2024年 | 23篇 |
2023年 | 213篇 |
2022年 | 401篇 |
2021年 | 731篇 |
2020年 | 677篇 |
2019年 | 603篇 |
2018年 | 730篇 |
2017年 | 651篇 |
2016年 | 489篇 |
2015年 | 569篇 |
2014年 | 1085篇 |
2013年 | 996篇 |
2012年 | 849篇 |
2011年 | 931篇 |
2010年 | 691篇 |
2009年 | 766篇 |
2008年 | 807篇 |
2007年 | 710篇 |
2006年 | 628篇 |
2005年 | 480篇 |
2004年 | 403篇 |
2003年 | 356篇 |
2002年 | 263篇 |
2001年 | 235篇 |
2000年 | 222篇 |
1999年 | 152篇 |
1998年 | 123篇 |
1997年 | 136篇 |
1996年 | 99篇 |
1995年 | 94篇 |
1994年 | 72篇 |
1993年 | 64篇 |
1992年 | 65篇 |
1991年 | 81篇 |
1990年 | 54篇 |
1989年 | 36篇 |
1988年 | 53篇 |
1987年 | 29篇 |
1986年 | 34篇 |
1985年 | 30篇 |
1984年 | 24篇 |
1983年 | 19篇 |
1982年 | 20篇 |
1981年 | 17篇 |
1980年 | 24篇 |
1979年 | 10篇 |
1978年 | 13篇 |
1977年 | 8篇 |
1976年 | 5篇 |
1975年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 203 毫秒
41.
目的探讨间接喉镜下或鼻内镜下微波热凝治疗声带息肉或小结的效果。方法对321例在间接喉镜或鼻内镜下微波热凝治疗声带息肉或小结病例资料进行分析。结果321例患者均一次手术成功。术后随诊3个月~一年以上的321例患者,治愈率92%,好转率8%。无效率为0。术中和术后未发生并发症。结论间接喉镜下或鼻内镜下微波热凝治疗声带息肉声带小结,具有操作安全、方便、不出血、快捷、简单、治愈率高等优点。 相似文献
42.
Permanent prostate brachytherapy for Japanese men: Results from initial 100 patients with prostate cancer 总被引:1,自引:1,他引:0
Toshikazu Okaneya Shuji Nishizawa Tsuyoshi Nakayama Takayuki Kamigaito Iwao Hashida Noriko Hosaka 《International journal of urology》2007,14(7):602-606
OBJECTIVE: To evaluate the initial results of brachytherapy for prostate cancer with permanent iodine-125 implant in Japan. METHODS: The results obtained with brachytherapy in the initial 100 Japanese patients treated at Nagano Municipal Hospital were reviewed. Patients with a prostate-specific antigen (PSA) level of less than 10 ng/mL and a Gleason's scores of 5, 6, 3 + 4 were classified as having a low risk of recurrence. Patients with a PSA level of 10-20 ng/mL and/or a Gleason's score of 4 + 3 were classified as having an intermediate risk for recurrence. Seventy-eight of the low-risk patients and 19 of the intermediate-risk patients were treated by seed implants alone, or seed implants combined with preceding external radiation, respectively. A total of 53 patients received neoadjuvant hormone therapy. The efficacy and morbidity of brachytherapy were investigated using the serum PSA, International Prostate Symptom Score, quality of life score and uroflowmetry data. RESULTS: The average V100 and D90 obtained by post-implant dosimetry was 94.3 and 113.7%, respectively. Serum PSA decreased gradually after treatment, although it had still not reached a nadir after 1 year. There was little difference of the PSA level between the patients with and without neoadjuvant hormone therapy even at 1 year after seed implantation. There were no PSA biochemical failure or clinical recurrence during the follow-up period. Voiding symptoms worsened until 3 months after treatment, and then gradually improved. Acute urinary retention occurred transiently in one patient (1%). Rectal bleeding and severe diarrhea did not occur. CONCLUSION: Brachytherapy is a feasible and effective option for the treatment of prostate cancer in Japanese men. Brachytherapy may have a different effect in Japanese patients with respect to voiding symptoms. Urinary retention was rare, but voiding symptoms were persistent in Japanese patients. Neoadjuvant hormone therapy deserves investigation to determine whether it can achieve better results, especially in patients with an intermediate risk. 相似文献
43.
本文通过酯交换反应合成了一系列脂肪族聚丁二酸酯,对他们的结构和性能作了表征。发现聚酯存在多晶现象,其熔点有奇偶性变化规律。探索了由此系列聚酯与高氯酸锂形成的固体电解质的结构和离子导电性。无机盐的加入提高了电解质的玻璃化温度但降低了聚酯的熔点及结晶度。聚酯电解质的晶体类似于聚酯,其无机盐主要溶解于聚酯的无定形区域。聚酯系列电解质的导电率也有偶奇效应,与熔点变化相反;熔点高的电解质导电率低,熔点低的电解质导电率高。电解质的导电率随温度改变而变化,在室温下电解质的导电率可达10~(-6)s/cm。高分子链上侧基的引入将大大降低电解质的导电性。 相似文献
44.
d-宁烯、丹参及姜黄素衍生物对ras基因产物膜结合和细胞间隙信息传导的影响 总被引:3,自引:0,他引:3
目的旨在寻找新型抗肿瘤药物,进一步研究d-宁烯、丹参及姜黄素衍生物的抗肿瘤机理。采用分子生物学方法及划痕标记染料示踪技术,研究了4种人实体瘤起源的细胞系的细胞间隙信息传导(GJIC)、H-ras癌基因表达以及ras癌基因产物(P21ras蛋白)表达状态,并观察了4种天然产物对它们的影响。结果表明,细胞内染料传输功能的丧失与ras基因突变率呈正相关;单萜化合物d-宁烯和酚类化合物丹参衍生物的抗肿瘤作用可能与抑制P21ras蛋白膜结合和增强细胞间隙信息传导功能有关。提示Ras癌基因产物P21ras蛋白膜结合的抑制与细胞间隙信息传导功能的增强有直接关系。 相似文献
45.
C. J. Bowden W. D. Figg N. A. Dawson O. Sartor R. J. Bitton M. S. Weinberger Donna Headlee Eddie Reed C. E. Myers M. R. Cooper 《Cancer chemotherapy and pharmacology》1996,39(1-2):1-8
Introduction: Suramin is a synthetic polysulfonated naphthylurea which has been used for the treatment of African trypanosomiasis and onchocerciasis,
but since the mid-1980s has received attention as a possible antiretroviral and antineoplastic agent. Objective: This clinical trial of suramin was undertaken as a phase I/II study in patients with hormone-refractory prostate cancer,
with the hypothesis that the intensity of therapy with suramin could be increased significantly if measures were undertaken
to maintain the plasma concentrations of the drug under 300 μg/ml. Methods: We report the clinical results of this trial, wherein patients were treated at three different targeted plasma suramin concentrations
(275, 215 and 175 μg/ml) for varying periods of time (2, 4 or 8 weeks), with delivery of the drug by continuous intravenous
infusion. Results: The major toxicity observed in this trial was neurologic, consisting of a motor and sensory peripheral neuropathy that resulted
in both paresis and paralysis of the limbs. Nearly all of this severe (CTEP grade III, IV) neurologic toxicity was observed
in the patients treated at a plasma suramin concentration of 275 μg/ml for 4 or more weeks. A single patient treated at 215 μg/ml
for 8 weeks developed moderate (CTEP grade III) proximal lower extremity weakness, and no patient treated at 175 μg/ml developed
this toxicity. The second most common toxicity observed was infection of the central venous catheter. The overall response
rate for all of the evaluable patients was 17% (13 of 75 patients). In addition, prostate-specific antigen (PSA)-defined responses
were observed in six patients receiving therapy at 175 μg/ml, but these responses were confounded by cessation of therapy
with flutamide during suramin treatment. Conclusions: In summary, although plasma suramin concentrations were maintained below 300 μg/ml, neurologic toxicity nonetheless occurred
with high frequency in patients treated at 275 μg/ml for 4 or more weeks. Therapy at 215 and 175 μg/ml was in general well
tolerated, but central venous catheter-related infection, as well as the inconvenience and expense of continuous infusional
therapy, make this method of drug delivery impractical. Only moderate antitumor activity was observed during this trial, but
it is possible that both continuation of flutamide and flutamide withdrawal during suramin therapy confounded the assessment
of suramin’s activity in hormone-refractory prostate cancer.
Received: 9 June 1995/Accepted: 18 March 1996 相似文献
46.
中老年人前列腺体积增长的城乡差异 总被引:27,自引:1,他引:26
为了解国人中年以后前列腺的生长情况及其可能的影响因素,对北京、河北、湖北等地四个社区的城乡居民前列腺体积进行了经腹B超测量。结果表明城区居民的前列腺体积明显大于相应年龄段的农村居民,城区居民的前列腺增长速率比农村居民高二倍。生活环境和饮食习惯的不同可能为其原因之一。 相似文献
47.
正常及良性前列腺增生组织中表皮生长因子活性的测定 总被引:3,自引:0,他引:3
为了解表皮生长因子在前列腺组织中的作用,利用免疫组织化学方法和竟争放射受体法对人正常和良性前列腺增生组织中表皮生长因子的组织定位和活性进行了检测。结果表明表皮生长因子主要定位于前列腺的分泌上皮细胞,正常前列腺和良性前列腺增生组织中表皮生长因子的活性无显著性差异。提示前列腺组织中表皮生长因子的主要作用可能并非在于调节前列腺上皮细胞的增殖。 相似文献
48.
前列腺带性结构及其雄激素、雌激素、表皮生长因子受体分布特征的研究 总被引:2,自引:0,他引:2
为了探讨雄激素受体(AR)、雌激素受体(ER)、孕激素受体(PR)和表皮生长因子受体(EGFR)在前列腺带性结构中的分布,应用单饱和剂量测定法,分别测定了前列腺移行带、外周带组织中AR、ER、PR和EGFR的含量。结果表明,在11例前列腺增生症(BPH)患者22份标本中,移行带和周围带AR全部阳性;尽管AR浓度个体差异很大,但是两带之间仍有密切相关性(P<0001);周围带AR浓度高于移行带,两带AR浓度均高于PR、ER;PR和ER在前列腺带性结构上没有明显差异。EGFR在移行带明显高于周围带。研究证实了AR、ER、PR,EGFR在前列腺移行带和周围带上的分布特征。 相似文献
49.
短发夹状RNA对PC-3M细胞端粒酶逆转录酶基因表达和端粒酶活性的影响 总被引:3,自引:0,他引:3
目的:研究短发夹状RNA(shRNA)对PC 3M细胞中端粒酶逆转录酶(hTRT)基因表达及端粒酶活 性的影响。方法:构建针对hTRT基因的shRNA表达质粒psilencer TRT,在质脂体介导下转染人前列腺癌PC 3M细胞,应用RT PCR及免疫组织化学检测hTRTmRNA及蛋白表达水平,应用SYBR Green染色法检测端粒 酶活性的变化。结果:重组体psilencer TRT转染细胞24h和48h后显著下调hTRTmRNA及蛋白水平,作用 48h后,其抑制率分别为85.39%和79.17%,较空白对照组差异有统计学意义(P<0.01)。同时,随着时间的延 长,端粒酶活性亦有明显下降(P<0.01)。结论:利用短发夹状RNA干扰技术能有效抑制靶基因的表达,为前 列腺癌的基因治疗提供新思路。 相似文献
50.
目的:探讨D期前列腺癌(PCa)患者药物去势治疗的效果与雄激素受体(AR)、前列腺特异性抗原(PSA)的相关性。方法:对33例D期PCa患者给予LHRH类似物 抗雄激素药物进行药物去势治疗,结合免疫组化进行统计分析。结果:AR、PSA与癌组织分化程度的之间的差异有统计学意义。Gleason不同评分组间血清PSA水平之间差异有统计学意义(P<0.05),PCa Gleason评分值与原位PSA免疫标记表达呈明显的负相关性(P<0.01);原位PSA免疫标记表达与血清PSA不具有相关性。结论:PCa组织中AR、PSA表达与D期PCa患者行药物去势疗法疗效有密切关系;血清PSA变化是监测PCa肿瘤复发与疗效的可靠瘤标。 相似文献